COMMERCIALIZATION ARCHITECTURE

The 6-Layer Decision Architecture

Traditional consulting delivers recommendations. Commercialization architecture delivers infrastructure. This framework sequences six decision layers, each resolving before the next begins, so commercial investment lands on structure rather than assumption.

Built on over 25 years inside the diagnostic ecosystem, beginning in 2002, this methodology replaces ad-hoc consulting with an operating system designed for the regulatory, reimbursement, and commercial dynamics of the in vitro diagnostics market.

The diagnostic industry does not lack innovation. It lacks commercialization architecture. This framework is the operating system between regulatory clearance and market adoption.

THE FRAMEWORK

Six Decision Layers for Diagnostic Commercialization

Market and Category Strategy

Define the market you will own and the category position that drives adoption. This layer sequences competitive positioning, care-setting priorities, and buyer pathway identification before capital is committed to launch. The goal is a defensible market thesis that aligns clinical utility with procurement logic.

KEY DELIVERABLES

Evidence and Adoption Strategy

Align clinical and economic data to payer and physician decision criteria. FDA clearance proves the test works (validity), but payers require proof that the test changes patient outcomes (utility). This layer closes the evidence gap by designing studies and data packages that satisfy both clinical and economic stakeholders.

Channel and Distribution Architecture

Design the distribution pathway that matches your product to its buyer. Channel selection in diagnostics is not a distribution decision: it is an architecture decision. The wrong channel can permanently constrain margin, limit geographic reach, and create dependency structures that become impossible to unwind.

Reimbursement and Access Strategy

Build the coverage and coding foundation that unlocks sustainable revenue. Without reimbursement infrastructure, even clinically superior diagnostics cannot sustain adoption beyond pilot programs. This layer sequences CPT/PLA coding strategy, coverage policy development, and payer engagement to compress the path from clearance to contracted revenue.

Launch Sequencing and Field Strategy

Stage market entry so every resource compounds toward early traction. Launch sequencing is not a timeline: it is a capital allocation decision. This layer determines which geographies, accounts, and evidence milestones are activated first, and in what order, to maximize the probability of self-sustaining adoption momentum.

Stakeholder and Investor Alignment

Ensure your commercial story holds up to diligence from funders and partners. Investors evaluate diagnostic companies on commercial architecture, not clinical promise. This layer structures the investor narrative, board reporting cadence, and milestone framework that converts scientific progress into investable commercial traction.

METHODOLOGY

Why Architecture, Not Consulting.

Traditional consulting delivers recommendations. Architecture delivers infrastructure. The difference is the gap between a strategy deck and a functioning commercial system.

Our methodology sequences six decision layers, each resolving before the next begins, so commercial investment lands on structure rather than assumption.

The result: diagnostic companies that launch with the operating model, pricing architecture, and channel logic already validated, not retroactively assembled after clearance.

THE COMMERCIAL ARCHITECTURE FRAMEWORK

Three Phases of Diagnostic Commercialization Architecture

Strategic Audit

DIAGNOSE BEFORE YOU BUILD

Every engagement begins with a rigorous assessment of commercialization readiness. We evaluate your evidence portfolio, reimbursement positioning, channel strategy, and launch sequencing to identify the structural gaps between regulatory progress and sustainable clinical adoption. The Strategic Audit produces a prioritized architecture brief that sequences your next 90 days of commercial decisions.

Structural Design

ARCHITECTURE, NOT ADVICE

Traditional consulting delivers recommendations. Commercialization architecture delivers infrastructure. We design the operating model, pricing logic, channel architecture, and evidence strategy required to convert FDA clearance into repeatable clinical adoption. Each layer resolves before the next begins, so commercial investment compounds on structure rather than assumption.

Guided Execution

FROM BLUEPRINT TO ADOPTION

Architecture without execution is decoration. We install the launch sequencing, field strategy, and stakeholder alignment systems that translate strategy into contracted clinical use. From first pilot placement through national distribution, AdvisoryDx provides the operational infrastructure that sustains adoption velocity beyond the initial commercial window.

THE PATHFINDING PROCESS

From Diagnostic to Commercial Readiness

The Illuminator

See the full landscape before you commit capital

The Foundation

Build the commercial operating system

The Blueprint

Execute with precision, not assumption

Ready to Install the Architecture?

Most engagements start with a 2-to-4 week Diagnostic Sprint that assesses commercialization readiness and produces a prioritized architecture brief.

SEE WHERE YOU STAND

Is your commercial architecture ready?

Take the 4-minute Readiness Assessment and see how your strategy scores across the six layers that drive clinical adoption.

STAY CURRENT

Subscribe to AdvisoryDx Insights

A monthly briefing on diagnostic market trends, competitive intelligence, product pricing, market-entry strategies, and commercial growth.

Recent topics: emerging diagnostic technologies, competitive market dynamics, pricing strategies, and distribution channel development.

Practical insights. No noise. Unsubscribe anytime.

NAVIGATE

RESOURCES

CONTACT

7901 4th St N, STE 300 St. Petersburg, FL 33702